Form 8-K - Current report:
SEC Accession No. 0001213900-25-056897
Filing Date
2025-06-24
Accepted
2025-06-24 07:15:08
Documents
16
Period of Report
2025-06-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246460-8k_enzo.htm   iXBRL 8-K 55258
2 AGREEMENT AND PLAN OF MERGER, DATED AS OF JUNE 23, 2025, BY AND AMONG BETHPAGE P ea024646001ex2-1_enzo.htm EX-2.1 590901
3 FORM OF WARRANT CANCELLATION AGREEMENT ea024646001ex10-1_enzo.htm EX-10.1 40168
4 FORM OF VOTING AND SUPPORT AGREEMENT ea024646001ex10-2_enzo.htm EX-10.2 56937
5 PRESS RELEASE OF ENZO BIOCHEM, INC., DATED JUNE 24, 2025 ea024646001ex99-1_enzo.htm EX-99.1 17042
  Complete submission text file 0001213900-25-056897.txt   1093050

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enzb-20250624.xsd EX-101.SCH 3002
7 XBRL LABEL FILE enzb-20250624_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE enzb-20250624_pre.xml EX-101.PRE 22350
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0246460-8k_enzo_htm.xml XML 3456
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 251066679
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)